tiprankstipranks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

34 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$2.48
$58.80M
-7.81
-64.11%
2 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$3.33
$127.87M
811.87
104.29%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$2.39
$136.92M
6.18
51.27%
4 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$2.32
$165.39M
-1.32
21.47%
5 Buy
0 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.82
$275.17M
-1.93
85.53%
4 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.87
$536.10M
-2.58
312.56%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
2.48
-4.34
-63.64%
AGEN
Agenus
3.33
1.49
80.98%
BDTX
Black Diamond Therapeutics
2.39
1.03
75.74%
NKTX
Nkarta
2.32
0.76
48.72%
CCCC
C4 Therapeutics
2.82
1.49
112.03%
KYTX
Kyverna Therapeutics, Inc.
8.87
6.96
364.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts